The Lilly Foundation has awarded the Biomedical Research Awards 2013 in the categories of preclinical and clinical research, respectively, to Dr. Andrés Moya, scientific director of the Centre Superior d’Investigació en Salut Pública de la Conselleria de Sanitat de la Generalitat Valenciana (CSISP-FISABIO), and Dr. Jaume Bosch, scientific director of CIBER of Hepatic and Digestive Diseases (CIBERehd) and professor of medicine at the Hospital Clínic – IDIBAPS of Barcelona. These awards, endowed with an amount of € 40,000 each, recognize excellence scientific career of researchers who have contributed to the development of Biomedicine and Health Sciences in Spain.
Archive for the ‘Hospital Clínic’ Category
Dr. Jaume Bosch, receives the Lilly Foundation Biomedical Research 2013 Award in the category of clinical research
Glucagon like peptide-1 (GLP-1) is a gut hormone related to insulin sensitivity. It has been suggested as a major factor for the improved glucose tolerance ensuing after Roux-en-Y Gastric Bypass (RYGBP) surgery. In this procedure, a stomach pouch is connected directly to the small intestine just beyond the duodenum. The remaining small intestine, with the rest of the stomach attached, is connected into a lower part of the intestine creating the “Y” shape that gives the technique its name. A work published in Diabetes Care suggests that the resolution of type 2 diabetes after RYGBP may be explained by mechanisms beyond enhancement of GLP-1 action. The first author of the paper is Dr. Amanda Jiménez, and Dr. Josep Vidal is the latter, both from the IDIBAPS team Diabetes: metabolic and molecular networks and the Endocrinology Service of the Hospital Clínic of Barcelona directed by Dr. Vidal.
Spanish Consortium for the Study of the Genome of the Chronic Lymphatic Leukemia, co-led by Dr. Elías Campo, links for the first time cancer with errors in the protection of chromosomes
A research published by Nature Genetics explores a new mechanism that may contribute to the development of diverse tumors, including chronic lymphatic leukemia, a form of cancer that affects thousands of new patients each year in Spain. The researchers have detected for the first time in a human cancer the mutation of an essential gene for the protection of the telomeres, situated on the edges of the chromosomes. The research, directed by Carlos López-Otín, of the University Institute of Oncology of the University of Oviedo, Elías Campo, of the Clínic Hospital/University of Barcelona, and María Blasco, director of the National Center of Oncological Research (CNIO), breaks new ground for the Spanish Consortium for the Study of the Genome of the Chronic Lymphatic Leukemia.
IDIBAPS investigators describe the genetic profile of an uncommon subtype of mantle cell lymphoma improving its proper diagnosis
Mantle cell lymphoma (MCL)is a subtype of B-cell lymphoma that comprises about 6-7% of all non-Hodgkin’s lymphoma cases. The main biomarker of this usually aggressive lymphoma is an alteration in Cyclin D1 expression. An article led by IDIBAPS investigators, and published in Blood(1), characterizes a new subtype of MCLs in which Cyclin D1 expression is not altered and offers clues to close different controversies about the genetics of the disease. Dr. Itziar Salaverria is the first author of the article, while the Miguel Servet investigator Dr. Sílvia Beà is the last one, both from the Human and experimental functional oncomorphology IDIBAPS team led by Dr. Elías Campo. Due to its significance, the article was highlighted by its editors as one of the “hottest” manuscripts to the media and selected for a comment (2) in the last issue of the Blood magazine.
BIO-Europe Spring is taking place in Barcelona from 11th to 13th March. It is the springtime counterpart to BIO-Europe, Europe’s largest partnering conference serving the global biotechnology industry. The event, held in Barcelona for the second time,continues the tradition of providing life science companies with high caliber partnering opportunities. The Innovation Management Office of the Clínic Foundation for Biomedical Research, a professional team that manages its own projects as well as innovation from Hospital Clínic of Barcelona, IDIBAPS and CRESIB, is there with a highly competitive portfolio of innovative ideas to be licensed.
On 16 February, Dr. Montse Palacio, from the Maternal Fetal Medicine service of the Hospital Clinic, received the Excellence Award of Research , one of the prestigious awards offered by the Society for Maternal-Fetal Medicine (SMFM). This award and the study, entitled Vaginal progesterone as maintenance treatment after an episode of preterm labor (PROMISE Study): a randomized, double blinded, placebo-controlled trial were presented as part of the thirteenth annual meeting of the SMFM, held in San Francisco from 11 to 16, February 2013. Read the rest of this entry »